Skip to content

Effects of Dry Needling and Strain Counter Strain Technique in Myofascial Trigger Points of Upper Trapezius

Combined Effects of Dry Needling and Strain Counter Strain Technique in Myofascial Trigger Points of Upper Trapezius

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04285216
Enrollment
28
Registered
2020-02-26
Start date
2019-09-15
Completion date
2020-08-28
Last updated
2020-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigger Point Pain, Myofascial

Keywords

Dry needling, Myofascial trigger points, Upper Trapezius, Strain counter strain

Brief summary

To determine the effects of Dry Needling and Strain Counter Strain Technique in Myofascial Trigger Points of Upper Trapezius

Detailed description

It is Randomized Controlled trail will be conduct in Mayo Hospital Lahore and Alnoor Hospital Awan town Lahore. Non probability consecutive sampling technique will be used to collect the data. Each group contain the 14 patients, Patient will be divided into two groups. Group A will be experimental group treated by Dry needling and strain counter strain with baseline treatment and Group B will be control group treated by Strain counter strain with baseline treatment(Hot pack 10 mints,stretching,Neck isometrics). Neck Disability index (NDI) ,visual analogue scale(VAS) and goniometer will be used as data collecting tools.

Interventions

OTHERDry Needling

Hot pack 10 mints,stretching,Neck isometrics, dry needling(DN) and Strain counterstrain(SCS)

Hot pack 10 mints, stretchings,Neck isometrics, Strain counterstrain(SCS)

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcome Assessor will be binded

Eligibility

Sex/Gender
ALL
Age
20 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Patients with non-specific neck pain, having active myofascial trigger points in upper trapezius muscle. * Patient of both gender under the age of 20-40 year * bilateral pain involving the upper trapezius * a duration of pain of at least 3 months * pain localized in the cervical and occipital regions but not in the orofacial region. * restricted cervical range of motion(side flexion)

Exclusion criteria

* history of traumatic injuries (e.g., contusion, fracture, and whiplash injury) * needle phobia patients. * systemic diseases such as blood coagula tion disorders, chronic pain syndrome, cancer,allergies fibromyalgia, systemic lupus erythematous, and psoriatic arthritis. * cervical spine surgery patients. * orofacial pain and temporomandibular disorders * neurologic disorders (e.g., trigeminal neuralgia or occipital neuralgia) * medical diagnosis of any primary headache (tension type or migraine) clinical diagnosis of cervical radiculopathy or myelopathy * history of previous physical therapy intervention for the cervical region in last 6 month * use of anticoagulants, opioids or antiepileptic medications

Design outcomes

Primary

MeasureTime frameDescription
Numeric Pain Rating Scale (NPRS)4 monthsThe Numerical Pain Rating Scale (NPRS) is a subjective measure in which individuals rate their pain on an eleven-point numerical scale. The scale is composed of 0 (no pain at all) to 10 (worst imaginable pain).
Range of Motion4 monthsStandard Goniometer will be used.Higher score shows improvement.

Secondary

MeasureTime frameDescription
Disability4 monthsScoring: For each section the total possible score is 5: if the first statement is marked the section score = 0, if the last statement is marked it = 5. If all ten sections are completed the score is calculated as follows: Example:16 (total scored) 50 (total possible score) x 100 = 32% If one section is missed or not applicable the score is calculated: 16 (total scored) 45 (total possible score) x 100 = 35.5% Minimum Detectable Change (90% confidence): 5 points or 10 %points

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026